Background/Objectives: Vitamin D is required for bone growth and normal insulin secretion. Maternal hypovitaminosis D may impair fetal growth and increase the risk of gestational diabetes. We have related maternal vitamin D status in pregnancy to maternal and newborn glucose and insulin concentrations, and newborn size, in a South Indian population. 
Introduction
The best-known function of vitamin D is the maintenance of calcium homeostasis through its actions on phosphate and calcium handling in the intestine, kidney and bone. Vitamin D is required throughout life for the normal growth and maintenance of bone. Its role in fetal skeletal growth is well established, and maternal vitamin D supplementation has been shown to increase birth weight and length in human studies. The most effective interventions have been in South Asian mothers with a high prevalence of vitamin D insufficiency (Brooke et al., 1980; Marya et al., 1981) .
Vitamin D is also required for the normal production and secretion of insulin by the endocrine pancreas, and possibly for normal insulin sensitivity (Clark et al., 1981; Boucher et al., 1995; Pittas et al., 2007) . In experimental animals, vitamin D deficiency impairs insulin release and glucose tolerance (Clark et al., 1980; Bikle, 1992) . In humans, it predicts increased glycaemia, and reduced insulin sensitivity and secretion in normoglycaemic subjects (Chiu et al., 2004; Hypponen and Power, 2006) . Serum 25 hydroxy vitamin D (25(OH)D) concentrations correlated positively with 30-min insulin concentrations, and negatively with glycaemia, during an oral glucose tolerance test (OGTT) in UK South Asians (Boucher et al., 1995) and it has been proposed that vitamin D deficiency may contribute to the increasing prevalence of type 2 diabetes, especially in South Asian populations (Boucher, 1998) .
Insulin is a growth-promoting hormone during fetal life, acting directly on fetal adipogenesis, and indirectly (on all body tissues) through stimulation of the insulin-like growth factors and their binding proteins (Fowden, 2003) . Maternal vitamin D status may therefore influence fetal growth partly through the insulin axis.
We have assessed maternal vitamin D status by measuring serum 25(OH)D in samples collected during a study of pregnant women in South India; the Parthenon Study. The original aim of this study was to determine the incidence of gestational diabetes and its effects on fetal growth. Stored serum samples were used to assess vitamin D status in this population, its seasonal variation and to examine whether maternal hypovitaminosis D at 30 weeks gestation is associated with (1) altered maternal glucose and insulin concentrations or an increased risk of gestational diabetes, (2) reduced fetal growth and (3) altered neonatal insulin concentrations. Because of recent interest in threshold effects of vitamin D (Hollis, 2005) , these associations were examined in the whole sample of women and separately in those with hypovitaminosis D (25(OH)D concentrations below 50 nmol l
À1
). This value was chosen because, although it is currently suggested that vitamin D depletion is defined by concentrations below 70-75 nmol l À1 (Vieth et al., 2007) , concentrations are known to be lower in pregnancy (Bouillon et al., 1981) .
Subjects and methods

Subjects
In 1997, the Mysore Parthenon Study recruited pregnant women attending the antenatal clinic at the Holdsworth Memorial Hospital (HMH), Mysore, South India Krishnaveni et al., 2005) . All women booking into the clinic were invited to participate. They were eligible for the study if they were non-diabetic before pregnancy, planned to deliver at HMH, had a singleton pregnancy and were o32 weeks gestation determined by the last menstrual period (LMP) or by a first trimester ultrasound scan if the LMP was uncertain. Of 1539 women interviewed, 10 were carrying twins, 198 planned delivery elsewhere and 98 booked too late, leaving 1233 eligible women, of whom only 830 (67%) participated. Ethical permission for the study was granted by HMH Research Ethics Committee and informed consent was obtained.
Clinic investigations
At 30±2 weeks gestation, maternal weight, height and skinfold thicknesses (biceps, triceps, subscapular and suprailiac) were measured using standardized methods by one of four trained observers. Socio-economic status was assessed using a standard questionnaire method, based on education, occupation and income (Kuppuswamy, 1962) .
Fasting blood was taken for measurement of plasma glucose, insulin and insulin precursor concentrations. A 100 g oral glucose load was administered and blood was taken 30, 60, 120 and 180-min later for plasma glucose and insulin concentrations. The OGTT was discontinued in 37 women due to vomiting, 4 did not wish to complete the OGTT and in 5 some samples were haemolysed. OGTT data were complete for 784 women. Plasma glucose concentrations were measured in Mysore using a standard hexokinase method. Gestational diabetes was diagnosed using the Carpenter and Coustan criteria (Carpenter and Coustan, 1982) , the standard method in clinical use in HMH. Aliquots of plasma were stored at À80 1C until the study was finished (up to 18 months) and transported in dry ice to the department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK, where glucose was re-measured using a standard hexokinase method, specific intact human insulin was measured by enzyme immunoassay (Medgenix, Florius, Belgium; coefficient of variation (CV) o10%, crossreactivity with proinsulin and 32-33 split proinsulin 0%), and proinsulin and 32-33 split proinsulin concentrations were measured by immunoradiometric assay (CVo7.5%) (Sobey et al., 1989; Alpha et al., 1992) .
Deliveries
In total 674 women delivered in HMH (81% of participants). Umbilical cord venous blood was sampled for plasma glucose, insulin, proinsulin and 32-33 split proinsulin assay. Neonatal anthropometric measurements were made immediately after birth by one of four trained observers, using standardized methods. Weight was measured on digital weighing scales (Seca, Germany, CMS Instruments Ltd., London, UK) and crown-heel length on a Harpenden neonatal stadiometre (CMS Instruments Ltd.). Head, chest (xiphisternum), abdomen (umbilicus) and mid-upper-arm circumferences were measured with blank anthropometric tape, marked and measured against a fixed ruler. Triceps and subscapular skinfold thicknesses were measured three times using Harpenden callipers (CMS Instruments Ltd.) and averaged.
Calcium and vitamin D supplements
At the time of the study, it was routine for general practitioners and obstetricians to prescribe calcium and vitamin D supplements to pregnant women from the beginning of the second trimester. A range of products was prescribed, according to each practitioner's preference, containing 500-1250 mg of calcium carbonate and 2.5 mg (100 IU)-7.5 mg (250 IU) of vitamin D3. Medications and supplements being taken by the women were recorded at recruitment, but not subsequently, and no information was therefore available on their use at 30 weeks gestation, when blood samples were taken, or at term.
Vitamin D analysis
Vitamin D status was assessed using stored serum samples from mothers who delivered at HMH, had a term delivery (X37 weeks gestation) and full OGTT data (n ¼ 574). Adequate samples were available for 559. Maternal serum 25(OH)D concentrations were measured using radioimmunoassay (IDS Immunodiagnostics Ltd., Boldon, Tyne and Wear, UK; intra-and inter-assay coefficients of variation 8.8 and 10.8%). Mothers were defined as having hypovitaminosis D at serum concentrations of 25(OH)D o50 nmol l À1 (Malabanan et al., 1998) .
Statistical analysis
The distributions of maternal body mass index (BMI), 25(OH)D concentrations, placental weight, and maternal and neonatal skinfold thicknesses, glucose, insulin and insulin precursor concentrations were skewed; these data were log-transformed for analysis. The 30-min insulin increment (30 min insulin-fasting insulin per 30 min glucose) was used as an index of maternal insulin secretion (Wareham et al., 1995) . Insulin resistance was estimated using the Homeostasis Model Assessment equation (HOMA) (Matthews et al., 1985) . Maternal fat mass was calculated using the four skinfolds (Van Raaij et al., 1988) . Birth measurements were adjusted to a gestational age of 40 weeks (sexes separately) using linear regression. The significance of seasonal variations in 25(OH)D concentrations and other variables was tested by Fourier's analysis, using the sum of sinusoidal curves of periodicity 1 year, 6 months and 4 months, to obtain the best fit. Relationships between maternal 25(OH)D concentrations and other maternal and neonatal variables were examined using multiple linear and logistic regression, using variables as continuous where appropriate. Analysis was carried out using STATA version 7.
Results
The median (interquartile range (IQR)) maternal serum 25(OH)D concentration was 37.8 (24.0, 58.5) (P ¼ 0.04). S e p -9 7 O c t -9 7 N o v -9 7 D e c -9 7 J a n -9 8 F e b -9 8 M a r -9 8 A p r -9 8 M a y -9 8 J u n -9 8 J u l -9 8 A u g -9 8 S e p -9 8 Month of Vitamin D sampling September-February and lowest during March-August. There was no seasonal variation in maternal or newborn glucose and insulin variables.
Seasonal variation
Maternal outcomes
There were no associations between 25(OH)D concentrations and maternal age, height, BMI or fat mass (Table 1) . Concentrations were similar in the 34 mothers with gestational diabetes (median 38.8 nmol l À1 ) to those in mothers with normal glucose tolerance (37.8 nmol l
À1
; P ¼ 0.8). Percentages of women with gestational diabetes were similar in women with and without hypovitaminosis D (7% in both groups). After adjustment for maternal age, fat mass and diabetes status, 25(OH)D concentrations were positively related to fasting 32-33 split proinsulin concentrations. There were no other associations between 25(OH)D concentrations and maternal outcomes; however, among women with hypovitaminosis D, 30-min glucose concentrations were inversely associated, and fasting proinsulin concentrations positively associated, with 25(OH)D concentrations.
Newborn outcomes
Mean birth weight (adjusted to 40 weeks gestation) was 3.0 kg, and was positively related to maternal weight, height, BMI and fat mass at 30 weeks gestation (Po0.001, 0.06, o0.001, o0.001). Gestational diabetes was associated with an increase in all neonatal measurements (mean (s.d.) birth weight 3262 (430) g as compared with 2889 (414) g for babies of mothers without diabetes; Po0.001). None of the neonatal body measurements, or cord plasma concentrations of glucose, insulin, proinsulin or 32-33 split proinsulin, were related to maternal 25(OH)D concentration (Table 1) . These findings were unchanged after excluding babies born to mothers with gestational diabetes. 
Discussion
A high proportion (66%) of mothers giving birth to full-term babies in one large maternity unit in the city of Mysore, India, had hypovitaminosis D, according to recognized criteria (Malabanan et al., 1998) Our study was limited to mothers booking into one hospital and was not population-based. Maternity services are not centralized in India, and in cities there is a wide choice of facilities. HMH charges patients but offers concessions for the poorest, providing a niche between free government hospitals and private nursing homes. Women who deliver there are of all religions, and mainly of middle and lower socio-economic status. The women in the original study were unselected consecutive attenders in the antenatal clinic, and the only selection for vitamin D analysis was on the basis of full-term delivery, complete OGTT data and adequacy of stored serum samples.
The high frequency of maternal hypovitaminosis D is consistent with findings in other studies (Sachan et al., 2005) . South Asians, both in their country of origin and after migration to Europe or the USA, have lower serum 25(OH)D concentrations as compared to white Caucasians (Awumey et al., 1998; Goswami et al., 2000; Hamson et al., 2003) due to skin pigmentation, covered-up clothing (especially common in women) and low dietary vitamin D intake. There may also be differences in vitamin D metabolism in South Asians; in vitro studies have shown that tissue fibroblasts have increased 25-hydroxy-24-hydroxylase activity, leading to increased catabolism of 25(OH)D and of activated vitamin D, 1,25(OH) 2 D (Awumey et al., 1998) . The expression of this enzyme is dose related to the habit of betel-nut chewing (Ogunkolade et al., 2006) ; we did not record betel chewing in Mysore, where it is generally practiced by women only on special occasions.
Because our study was not originally designed to examine vitamin D status, we did not collect data on supplement use at 30 weeks gestation, but only at recruitment. Women not on supplements at recruitment may have been prescribed them later in pregnancy, while those prescribed supplements in early pregnancy may have stopped taking them by 30 weeks. Paradoxically, mothers taking supplements at recruitment had lower 25(OH)D concentrations at 30 weeks, suggesting that information collected at recruitment probably bore little relationship to supplement usage in late pregnancy. We can, however, conclude that despite the frequent prescription of calcium and vitamin D during the second trimester (generally 250 IU or less), many mothers had hypovitaminosis D in late pregnancy.
Seasonal variation in serum 25(OH)D concentrations in Mysore (latitude 12.31 north) is probably related to sunlight exposure. Low concentrations in winter are described in European and US populations (Kuoppala et al., 1986; Sherman et al., 1990; Van der Wielen et al., 1995) and concentrations vary with season and correlate with sun exposure in India and other Asian countries (Goswami et al., 2000; Kim and Moon, 2000; Nakamura et al., 2000) . We have no sunlight exposure data for our women, but it is likely to have been lowest during the rainy season (June-August) and hottest summer months when people avoid the sun (MarchMay). 25(OH)D concentrations were highest in the sunny, but cooler, months of September-February.
We found no relationship in Mysore between maternal vitamin D status at 30 weeks and neonatal size, either with or without the inclusion of babies of diabetic mothers. Trials of vitamin D supplementation in pregnant Asian women have shown improvements in maternal and neonatal biochemical indices of calcium and vitamin D status, and higher birth weight and length (Marya et al., 1988) . Canadian women with higher milk and/or vitamin D intakes had heavier babies (Mannion et al., 2006) . Australian women with higher 25(OH)D concentrations in late pregnancy had babies with longer knee-heel length (Morley et al., 2006) . In contrast, an early study of UK Asian women showed no correlation between maternal 25(OH)D concentrations and birth weight (Dent and Gupta, 1975) . The discrepancy between our data and reported interventional data may reflect the timing of our 25(OH)D measurements. In trials, supplementation has usually been given throughout the last trimester, whereas vitamin D status was assessed at the beginning of the last trimester in our study. Since fetal growth is rapid during the last trimester, measurements made later in pregnancy or at birth may have shown associations. Alternatively, vitamin D concentrations in Mysore may all have been below those required for optimal fetal growth (Hollis and Wagner, 2006) . Our mothers may have lacked other nutrients relevant to vitamin D function, such as vitamin A, often deficient in pregnancy in India (Singh and Toteja, 2003) , since activated vitamin D exerts its main effects through complexation of the activated vitamin D receptor (VDR) with the retinol-X receptor (Colston, 1993) . Additionally, low serum 25(OH)D concentrations may be compensated for by placental synthesis of 1,25(OH) 2 D (Seely et al., 1997) . Indian newborns are approximately 500 g lighter at birth as compared to white Caucasian babies born in Europe. Reasons are thought to include smaller maternal size and poorer nutrition. Another reason for the absence of associations between maternal vitamin D were concentrations and newborn size in Mysore could be that effects of vitamin D were masked by other maternal nutritional deficiencies.
The absence of associations between maternal vitamin D status at 30 weeks gestation and neonatal anthropometry in our study does not preclude other important effects on fetal development since maternal deficiency leads to infantile rickets (Pawley and Bishop, 2004) and postnatal growth failure (Brooke et al., 1981) . Variations in maternal vitamin D status are related to neonatal and childhood bone mineral content (Namgung et al., 1994; Javaid et al., 2006) .
Pancreatic b-cells express the VDR, and insulin secretion in South Asians is impaired during vitamin D deficiency and improved by cholecalciferol administration (Boucher et al., 1995) . Thus, the high prevalence of vitamin D insufficiency in South Asians, could contribute to their high incidence of type 2 diabetes (Boucher, 1998) . There is little information on vitamin D status and gestational diabetes, but maternal hypovitaminosis D has been reported in diabetic pregnancies in Spain (Martinez et al., 1991) , and fasting glycaemia fell with vitamin D supplementation in one small study of women with gestational diabetes (Rudnicki and Mølsted-Pedersen, 1997) This is the first study in South Asians to measure neonatal insulin and its precursors in relation to maternal 25(OH)D concentrations. There were no associations. A recent study of White Caucasian UK neonates showed an inverse association between 34-week maternal 25(OH)D concentrations and cord proinsulin concentrations (Boucher et al., 2003) .
In conclusion, our findings did not support our starting hypotheses, and showed no evidence that hypovitaminosis D is an important contributing factor to gestational diabetes at 30 weeks gestation, or impaired fetal growth in this population. Further, prospective studies are required, including studies in later pregnancy, since fetal insulin responses to glucose develop late in pregnancy (Hellerstrom and Swenne, 1991) . The results of randomized controlled trials of vitamin D supplementation in pregnancy, now in progress, are awaited with interest (Hollis and Wagner, 2006) .
